1.
de Mola Loret J. Obesity and its relationship to infertility in men and women. Obstetrics
and gynecology clinics of North America. 2009;36(2):333-46, ix.
2.
Talmor A, Dunphy B. Female obesity and infertility. Best Practice & Research Clinical
Obstetrics & Gynaecology. 2015;29(4):498-506.
3.
Hensrud DD, Klein S, editors. Extreme obesity: a new medical crisis in the United
States. Mayo Clinic Proceedings; 2006: Elsevier.
4.
Brown III CH. Obesity and cancer. Obesity: CRC Press; 2012. p. 360-71.
5.
Bastien M, Poirier P, Lemieux I, Després J-P. Overview of epidemiology and contribution
of obesity to cardiovascular disease. Progress in cardiovascular diseases. 2014;56(4):369-81.
6.
Pasquali R, Patton L, Gambineri A. Obesity and infertility. Current Opinion in Endocrinology,
Diabetes and Obesity. 2007;14(6):482-7.
7.
Best D, Bhattacharya S. Obesity and fertility. Hormone molecular biology and clinical
investigation. 2015;24(1):5-10.
8.
Koning A, Kuchenbecker W, Groen H, Hoek A, Land J, Khan K, et al. Economic consequences
of overweight and obesity in infertility: a framework for evaluating the costs and
outcomes of fertility care. Human reproduction update. 2010;16(3):246-54.
9.
Eijkemans MJ, Imani B, Mulders AG, Habbema JDF, Fauser BC. High singleton live birth
rate following classical ovulation induction in normogonadotrophic anovulatory infertility
(WHO 2). Human Reproduction. 2003;18(11):2357-62.
10.
Rowe PJ, Comhaire FH, Hargreave TB, Mellows HJ, Organization WH. WHO manual for the
standardized investigation and diagnosis of the infertile couple. 1993.
11.
Weiss RV, Clapauch R. Female infertility of endocrine origin. Arquivos Brasileiros
de Endocrinologia & Metabologia. 2014;58(2):144-52.
12.
ESHRE TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term
health risks related to polycystic ovary syndrome. Fertility and sterility. 2004;81(1):19-25.
13.
Mannerås-Holm L, Leonhardt H, Kullberg J, Jennische E, Odén A, Holm G, et al. Adipose
tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum
adiponectin, but not circulating sex steroids, are strongly associated with insulin
resistance. The Journal of Clinical Endocrinology & Metabolism. 2011;96(2):E304-E11.
14.
Mitchell M, Armstrong D, Robker R, Norman R. Adipokines: implications for female fertility
and obesity. Reproduction. 2005;130(5):583-97.
15.
Lecke S, Morsch D, Spritzer P. Association between adipose tissue expression and serum
levels of leptin and adiponectin in women with polycystic ovary syndrome. Genet Mol
Res. 2013;12(4):4292-6.
16.
Svendsen PF, Christiansen M, Hedley PL, Nilas L, Pedersen SB, Madsbad S. Adipose expression
of adipocytokines in women with polycystic ovary syndrome. Fertility and sterility.
2012;98(1):235-41.
17.
Sarray S, Madan S, Saleh LR, Mahmoud N, Almawi WY. Validity of adiponectin-to-leptin
and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome. Fertility
and sterility. 2015;104(2):460-6.
18.
Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, et al. Adiponectin
is independently associated with insulin sensitivity in women with polycystic ovary
syndrome. Clinical endocrinology. 2004;61(6):738-46.
19.
Plati E, Kouskouni E, Malamitsi-Puchner A, Boutsikou M, Kaparos G, Baka S. Visfatin
and leptin levels in women with polycystic ovaries undergoing ovarian stimulation.
Fertility and sterility. 2010;94(4):1451-6.
20.
Escobar-Morreale H, Villuendas G, Botella-Carretero J, Alvarez-Blasco F, Sanchon R,
Luque-Ramirez M, et al. Adiponectin and resistin in PCOS: a clinical, biochemical
and molecular genetic study. Human Reproduction. 2006;21(9):2257-65.
21.
Golbahar J, Das NM, Al-Ayadhi MA, Gumaa K. Leptin-to-adiponectin, adiponectin-to-leptin
ratios, and insulin are specific and sensitive markers associated with polycystic
ovary syndrome: a case–control study from Bahrain. Metabolic syndrome and related
disorders. 2012;10(2):98-102.
22.
Owiredu E-W, Dontoh E, Essuman SE, Bazanfara BB. Demographic and Lifestyle Predictors
of Prehypertension: A Cross-Sectional Study among Apparently Healthy Adults in Kumasi,
Ghana. BioMed Research International. 2019;2019.
24.
Freedman D, Thornton J, Pi‐Sunyer F, Heymsfield S, Wang J, Pierson R, et al. The body
adiposity index (hip circumference÷ height1. 5) is not a more accurate measure of
adiposity than is BMI, waist circumference, or hip circumference. Obesity. 2012;20(12).
doi: 10.1038/oby.2012.81.
25.
Team RC. R: A language and environment for statistical computing. 2013.
26.
Baldani DP, Skrgatic L, Kasum M, Zlopasa G, Kralik Oguic S, Herman M. Altered leptin,
adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic
ovary syndrome abnormality. Gynecological Endocrinology. 2019:1-5.
27.
Olszanecka-Glinianowicz M, Kuglin D, Dąbkowska-Huć A, Skałba P. Serum adiponectin
and resistin in relation to insulin resistance and markers of hyperandrogenism in
lean and obese women with polycystic ovary syndrome. European Journal of Obstetrics
& Gynecology and Reproductive Biology. 2011;154(1):51-6.
28.
Xiu-e L, He-feng H, Mei-gen L, Yi-min Z, Yu-li Q, Min-yue D. Resistin levels of serum
and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF
cycles. Journal of Zhejiang University Science B. 2005;6(9):897-902.
29.
Arikan Ş, Bahceci M, Tuzcu A, Kale E, Gökalp D. Serum resistin and adiponectin levels
in young non-obese women with polycystic ovary syndrome. Gynecological Endocrinology.
2010;26(3):161-6.
30.
Seow KM, Juan CC, Wu LY, Hsu YP, Yang WM, Tsai YL, et al. Serum and adipocyte resistin
in polycystic ovary syndrome with insulin resistance. Human Reproduction. 2004;19(1):48-53.
31.
Campos D, Palin M, Bordignon V, Murphy B. The ‘beneficial’adipokines in reproduction
and fertility. International Journal of Obesity. 2008;32(2):223.
32.
Budak E, Sánchez MF, Bellver J, Cerveró A, Simón C, Pellicer A. Interactions of the
hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive
system. Fertility and sterility. 2006;85(6):1563-81.
33.
Dong M, Ren J. What fans the fire: insights into mechanisms of leptin in metabolic
syndrome-associated heart diseases. Current pharmaceutical design. 2014;20(4):652-8.
34.
Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba B, Murphy LJ. Plasma resistin, adiponectin
and leptin levels in lean and obese subjects: correlations with insulin resistance.
European journal of endocrinology. 2003;149(4):331-5.
35.
Gerrits AJ, Gitz E, Koekman CA, Visseren FL, van Haeften TW, Akkerman JWN. Induction
of insulin resistance by the adipokines resistin, leptin, plasminogen activator inhibitor-1
and retinol binding protein 4 in human megakaryocytes. haematologica. 2012;97(8):1149-57.
36.
Azuma K, Oguchi S, Matsubara Y, Mamizuka T, Murata M, Kikuchi H, et al. Novel resistin
promoter polymorphisms: association with serum resistin level in Japanese obese individuals.
Hormone and metabolic research. 2004;36(08):564-70.
37.
Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, et al. Circulating
resistin levels are not associated with obesity or insulin resistance in humans and
are not regulated by fasting or leptin administration: cross-sectional and interventional
studies in normal, insulin-resistant, and diabetic subjects. The Journal of Clinical
Endocrinology & Metabolism. 2003;88(10):4848-56.
38.
Chen C-C, Li T-C, Li C-I, Liu C-S, Wang H-J, Lin C-C. Serum resistin level among healthy
subjects: relationship to anthropometric and metabolic parameters. Metabolism. 2005;54(4):471-5.